Mammography Devices Market to Grow with a CAGR of 5.75% through 2030

Increasing prevalence of breast cancer and technological advancements in breast imaging is expected to drive the Global Mammography Devices Market growth in the forecast period, 2026-2030.

According to TechSci Research report, “Mammography Devices Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030F”, the Global Mammography Devices Market stood at USD 2.74 Billion in 2024 and is anticipated to grow with a CAGR of 5.75% in the forecast period, 2026-2030.

The global demand for mammography devices is witnessing robust growth, driven by a combination of increasing breast cancer incidence, intensified public health initiatives, and technological advancements in diagnostic imaging. The primary growth catalysts is the rising global burden of breast cancer, which remains a leading cause of cancer-related mortality among women. Early detection is critical, yet often challenging, especially in early-stage disease. Mammography systems play a pivotal role by enabling high-resolution imaging of breast tissue, thereby facilitating timely identification of abnormalities and supporting earlier diagnosis. This clinical utility is fueling widespread adoption across healthcare systems.

Government-led awareness campaigns and non-governmental health outreach programs have significantly contributed to improving public understanding of breast cancer and the importance of regular screening. These efforts have led to a measurable increase in screening uptake rates, particularly in high-risk populations, which in turn is expanding the installed base of mammography devices.

In the United States, programs such as the Health Resources and Services Administration’s (HRSA) Federal Consolidated Health Centers initiative aim to extend screening services to medically underserved areas, providing subsidized or free access to diagnostic tools. At the state level, New York’s breast cancer screening initiative, supported under Governor Cuomo’s leadership, is an example of targeted policy efforts aimed at enhancing early detection, especially for low-income populations.

On the technological front, advancements in digital mammography and 3D tomosynthesis are improving diagnostic accuracy while minimizing patient discomfort. Newer systems are capable of capturing high-contrast digital images with lower radiation exposure and reduced compression pressure, enhancing both clinical effectiveness and patient compliance. Additionally, digital integration capabilities such as soft-copy image reading and seamless data transfer are streamlining workflows in diagnostic centers and hospitals.

The growing demand for routine health monitoring, the expansion of healthcare infrastructure in emerging economies, and the increasing penetration of portable and AI-enhanced mammography systems are expected to sustain market momentum. With these combined factors, the mammography devices market is positioned for steady growth throughout the forecast period, supported by rising screening volumes and evolving clinical standards for breast cancer detection.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Mammography Devices Market”

The Global Mammography Devices Market is segmented into product type, technology, end user, regional distribution, and company.

Based on its product, the Full-Field Digital Mammography segment dominated the Global Mammography Devices Market. FFDM systems replaced traditional analog (film-screen) mammograms by offering digitally acquired, high-resolution images, which significantly enhance the visibility of breast tissues and abnormalities. These systems are widely favored for: Greater image clarity and contrast, especially in women with dense breast tissue. Immediate image availability, allowing faster diagnosis and workflow efficiency. Reduced need for retakes, minimizing radiation exposure and operational costs. FFDM serves as the clinical standard of care in most developed healthcare systems, making it the default choice for both routine screening and diagnostic follow-up.

FFDM has achieved the widest market penetration across hospitals, diagnostic imaging centers, and mobile screening units. Its scalability and compatibility with existing Picture Archiving and Communication Systems (PACS) and Radiology Information Systems (RIS) have accelerated its adoption, particularly in: North America and Europe, where regulatory frameworks strongly encourage the use of digital imaging for breast cancer screening. Asia-Pacific and Latin America, where healthcare digitization is underway, and FFDM is often preferred for its balance between affordability and advanced functionality. FFDM’s well-established global presence gives it a considerable lead over newer modalities in terms of volume, revenue share, and installed base. From a procurement and operational standpoint, FFDM systems offer: Lower total cost of ownership compared to advanced technologies like breast tomosynthesis. Faster throughput and streamlined workflow, enabling high-volume screening programs, particularly in national or regional public health initiatives. Integration with AI tools, further enhancing diagnostic accuracy, prioritization of cases, and radiologist productivity. These efficiencies are particularly valuable for healthcare providers under financial or staffing constraints, reinforcing FFDM's dominance in both mature and emerging markets.

Based on region, The Asia Pacific region is expected to witness the fastest growth rate in the global mammography devices market during the forecast period. This upward trajectory is being driven by a combination of rising breast cancer incidence, improved healthcare infrastructure, increasing awareness and screening programs, and favorable government policies that are accelerating the adoption of diagnostic imaging technologies across both developed and emerging economies in the region. The Asia Pacific region is experiencing a notable increase in breast cancer cases, particularly in densely populated countries such as India and China. According to global cancer statistics, breast cancer has overtaken cervical cancer as the most prevalent cancer among women in Asia. This escalating disease burden is prompting governments and healthcare providers to expand early detection initiatives and invest in mammography systems. Urbanization and lifestyle changes are contributing to higher cancer risk. An aging female population is increasing the demand for routine screening. 

Major companies operating in Global Mammography Devices Market are:

• Hologic, Inc.
• Fujifilm Holdings Corporation
• Philips Healthcare
• Siemens Healthineers AG
• GE Healthcare
• Carestream Health, Inc.
• Konica Minolta Inc.
• Delphinus Medical Technologies, Inc.
• Analogic Corporation
• KUB Technologies, Inc.

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The increasing global prevalence of breast cancer is a key driver for market growth. Furthermore, growing awareness of available treatment options, the benefits of screening and early diagnosis, and technological advancements in imaging solutions are additional factors fueling this growth. For example, innovative 3-Dimensional, non-ionizing, and ionizing imaging solutions such as Full-field digital mammography (FFDM) and Digital Breast Tomosynthesis (DBT) systems provide enhanced precision through the generation of 3D image sets. Additionally, the availability of rental services for digital mammography systems in public hospitals and diagnostic centers contributes to market expansion by providing cost-effective imaging solutions. Significant improvements in healthcare infrastructure and favorable government policies promoting public health are also expected to drive market growth”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Mammography Devices Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product Type (Full-field Digital Mammography, Film-screen Mammogram, Breast Tomosynthesis), By Technology (Digital, Analog), By End User (Hospitals & Clinics, Diagnostic Centres, Others), By Region, & Competition, 2020-2030F”, has evaluated the future growth potential of Global Mammography Devices Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Mammography Devices Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com